.png){kind=logo}
Sigma Aldrich (6,871)
Formoterol Related Compound C
United States Pharmacopeia (USP) Reference StandardMF: (C₂₀H₂₆N₂O₄)₂ · C₄H₄O₄ / MW: 832.94
Oxcarbazepine Related Compound D
United States Pharmacopeia (USP) Reference StandardMF: C₃₀H₂₂N₄O₃ / MW: 486.52
Fluocortolone pivalate for peak identification CRS
European Pharmacopoeia (EP) Reference StandardCAS No: 29205-06-9 / MF: C₂₇H₃₇FO₅ / MW: 460.58
Terazosin impurity E
European Pharmacopoeia (EP) Reference StandardCAS No: 102839-00-9 / MF: C₂₄H₂₈N₈O₄ / MW: 492.53
Loxapine N-oxide
United States Pharmacopeia (USP) Reference StandardCAS No: 25967-34-4 / MF: C₁₈H₁₈ClN₃O₂ / MW: 343.81
Perindopril Related Compound F
United States Pharmacopeia (USP) Reference StandardCAS No: 129970-98-5 / MF: C₁₉H₃₀N₂O₄ / MW: 350.45
Aminophenylmorpholinone
Pharmaceutical Analytical Impurity (PAI)CAS No: 438056-69-0 / MF: C₁₀H₁₂N₂O₂ / MW: 192.21
Desflurane Related Compound A
United States Pharmacopeia (USP) Reference StandardCAS No: 67429-44-1 / MF: C₄H₂F₈O / MW: 218.05
Sodium aminosalicylate dihydrate for equipment qualification
European Pharmacopoeia (EP) Reference StandardCAS No: 6018-19-5 / MF: C₇H₆NNaO₃ · 2H₂O / MW: 211.15
Cannabidiol impurity J
European Pharmacopoeia (EP) Reference StandardCAS No: 35482-50-9 / MF: C₁₇H₂₂O₂ / MW: 258.36
Folic acid for impurity I identification
European Pharmacopoeia (EP) Reference StandardCAS No: 59-30-3 / MF: C₁₉H₁₉N₇O₆ / MW: 441.40
Indinavir for system suitability
European Pharmacopoeia (EP) Reference StandardCAS No: 180683-37-8 / MF: C₃₆H₄₇N₅O₄ · H₂O / MW: 631.80
Vardenafil Related Compound E
United States Pharmacopeia (USP) Reference StandardCAS No: 448184-46-1 / MF: C₂₁H₂₈N₆O₄S / MW: 460.55
Mirtazapine
United States Pharmacopeia (USP) Reference StandardCAS No: 85650-52-8 / MF: C₁₇H₁₉N₃ / MW: 265.35
Polyoxyl 2 stearyl ether
United States Pharmacopeia (USP) Reference StandardCAS No: 9005-00-9
Dopamine Related Compound A
United States Pharmacopeia (USP) Reference StandardMF: C₉H₁₃NO₂ / MW: 167.21
Boldine for system suitability
European Pharmacopoeia (EP) Reference StandardCAS No: 476-70-0 / MF: C₁₉H₂₁NO₄ / MW: 327.37
1,3-Dimethyl-6-nitroindazole
Pharmaceutical Analytical Impurity (PAI)CAS No: 1354224-47-7 / MF: C₉H₉N₃O₂ / MW: 191.19
Advantame Acid
United States Pharmacopeia (USP) Reference StandardCAS No: 713524-95-9 / MF: C₂₃H₂₈N₂O₇ / MW: 444.48
Rabies vaccine (inactivated), for veterinary use
BRP, European Pharmacopoeia (EP) Reference Standard
Sorafenib tosilate
CRS, European Pharmacopoeia (EP) Reference StandardCAS No: 475207-59-1 / MF: C₂₁H₁₆ClF₃N₄O₃·C₇H₈SO₃ / MW: 637.03
Testosterone decanoate
European Pharmacopoeia (EP) Reference StandardCAS No: 5721-91-5 / MF: C₂₉H₄₆O₃ / MW: 442.67
Ranolazine Related Compound A
United States Pharmacopeia (USP) Reference StandardCAS No: 2210-74-4 / MF: C₁₀H₁₂O₃ / MW: 180.20
Flutamide
United States Pharmacopeia (USP) Reference StandardCAS No: 13311-84-7 / MF: C₁₁H₁₁F₃N₂O₃ / MW: 276.21
α-Amylcinnamaldehyde dimethyl acetal
United States Pharmacopeia (USP) Reference StandardCAS No: 91-87-2 / MF: C₁₆H₂₄O₂ / MW: 248.36
Venlafaxine Related Compound E
United States Pharmacopeia (USP) Reference StandardCAS No: 93413-56-0 / MF: C₁₇H₂₅NO₂· ClH / MW: 311.85
Dolasetron mesylate Related Compound A
United States Pharmacopeia (USP) Reference StandardMF: C₁₀H₁₅NO₂ · HCl / MW: 217.69
Salmeterol Related Compound B
United States Pharmacopeia (USP) Reference StandardCAS No: 108928-81-0 / MF: C₂₅H₃₇NO₄ / MW: 415.57
Rivastigmine Related Compound F
United States Pharmacopeia (USP) Reference StandardCAS No: 1346602-84-3 / MF: C₁₂H₁₅NO₂ / MW: 205.25
Selenium Sulfide
United States Pharmacopeia (USP) Reference StandardCAS No: 7488-56-4 / MF: SeS₂ / MW: 143.09
Cellulose acetate phthalate
European Pharmacopoeia (EP) Reference StandardCAS No: 9004-38-0
Magnesium citrate
United States Pharmacopeia (USP) Reference StandardCAS No: 3344-18-1 / MF: C₁₂H₁₀Mg₃O₁₄ / MW: 451.11
Sulfamethizole for system suitability
CRS, European Pharmacopoeia (EP) Reference StandardCAS No: 144-82-1 / MF: C₉H₁₀N₄O₂S₂ / MW: 270.33
Duloxetine Phenylcarbamate
Pharmaceutical Analytical Impurity (PAI)CAS No: 947686-09-1 / MF: C₂₅H₂₃NO₃S / MW: 417.52
Tetracaine hydrochloride
European Pharmacopoeia (EP) Reference StandardCAS No: 136-47-0 / MF: C₁₅H₂₄N₂O₂ · HCl / MW: 300.82
Oxaliplatin impurity B
European Pharmacopoeia (EP) Reference StandardMF: C₆H₁₈N₂O₂Pt / MW: 345.30
Tazobactam Related Compound A
United States Pharmacopeia (USP) Reference StandardCAS No: 120701-87-3 / MF: C₇H₁₂N₄O₄S / MW: 248.26
Tiotropium Related Compound C
United States Pharmacopeia (USP) Reference StandardCAS No: 136310-95-7 / MF: C₁₉H₂₂BrNO₃S₂ / MW: 456.42
amino}ethyl)phenyl)formamide fumarate](/shopimages/thelab2017/0130020071293.jpg?1765366220)
N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl](methyl)amino}ethyl)phenyl)formamide fumarate
Oleyl oleate
United States Pharmacopeia (USP) Reference StandardCAS No: 3687-45-4 / MF: C₃₆H₆₈O₂ / MW: 532.92
Nimodipine impurity A
European Pharmacopoeia (EP) Reference StandardCAS No: 85677-93-6 / MF: C₂₁H₂₄N₂O₇ / MW: 416.42
Decitabine Related Compound E
United States Pharmacopeia (USP) Reference StandardCAS No: 22432-95-7 / MF: C₈H₁₂N₄O₄ / MW: 228.21
Docosahexaenoic Acid
United States Pharmacopeia (USP) Reference StandardCAS No: 6217-54-5 / MW: 328.49
Residual Solvent Class 1 - Carbon Tetrachloride
United States Pharmacopeia (USP) Reference StandardCAS No: 56-23-5
Acamprosate calcium CRS
European Pharmacopoeia (EP) Reference StandardCAS No: 77337-73-6 / MF: C₅H₁₀Ca0.5NO₄S / MW: 200.24
Hydroxocobalamin chloride
United States Pharmacopeia (USP) Reference StandardCAS No: 59461-30-2 / MF: C₆₂H₈₉CoN₁₃O₁₅P · HCl / MW: 1382.82
Isotachysterol3
Pharmaceutical Analytical Impurity (PAI)CAS No: 22350-43-2 / MF: C₂₇H₄₄O / MW: 384.64
Mitotane Related Compound A
United States Pharmacopeia (USP) Reference StandardCAS No: 72-54-8 / MF: C₁₄H₁₀Cl₄ / MW: 320.04
Tropicamide Related Compound A
United States Pharmacopeia (USP) Reference StandardCAS No: 33403-97-3 / MF: C₈H₁₂N₂ / MW: 136.19
Cidofovir Related Compound B
United States Pharmacopeia (USP) Reference StandardCAS No: 120362-35-8 / MF: C₁₂H₂₂N₃O₆P · HCl / MW: 371.75
Butyl cinnamate
United States Pharmacopeia (USP) Reference StandardCAS No: 538-65-8 / MF: C₁₃H₁₆O₂ / MW: 204.26
Orlistat Related Compound B
United States Pharmacopeia (USP) Reference StandardCAS No: 19740-72-8 / MF: C₈H₁₆N₂O₄ / MW: 204.22
Tazarotene
United States Pharmacopeia (USP) Reference StandardCAS No: 118292-40-3 / MF: C₂₁H₂₁NO₂S / MW: 351.46
Oxymetazoline hydrochloride
European Pharmacopoeia (EP) Reference StandardCAS No: 2315-02-8 / MF: C₁₆H₂₄N₂O · HCl / MW: 296.84
Didanosine for system suitability
European Pharmacopoeia (EP) Reference StandardCAS No: 69655-05-6 / MF: C₁₀H₁₂N₄O₃ / MW: 236.23
Nicardipine for system suitability
European Pharmacopoeia (EP) Reference StandardCAS No: 54527-84-3 / MF: C₂₆H₂₉N₃O₆ · HCl / MW: 515.99
ᴅ-His-Protirelin
European Pharmacopoeia (EP) Reference StandardCAS No: 40600-90-6 / MF: C₁₆H₂₂N₆O₄ / MW: 362.38
![N-{1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutyl}-N-methylamine hydrochloride](/shopimages/thelab2017/0130020070403.jpg?1765366205)
N-{1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutyl}-N-methylamine hydrochloride
5-Me Bz Dc Beta-Cyanoethyl Phosphoramidite
United States Pharmacopeia (USP) Reference StandardCAS No: 105931-57-5 / MF: C₄₇H₅₄N₅O₈P / MW: 847.93
Escitalopram
European Pharmacopoeia (EP) Reference StandardCAS No: 128196-01-0 / MF: C₂₀H₂₁FN₂O / MW: 324.39
Testosterone Cypionate Related Compound A
United States Pharmacopeia (USP) Reference Standard
Perphenazine for system suitability
European Pharmacopoeia (EP) Reference StandardCAS No: 58-39-9 / MF: C₂₁H₂₆ClN₃OS / MW: 403.97
Azacitidine Related Compound B
United States Pharmacopeia (USP) Reference StandardCAS No: 6974-32-9 / MF: C₂₈H₂₄O₉ / MW: 504.48
Deferasirox
CRS, European Pharmacopoeia (EP) Reference StandardCAS No: 201530-41-8 / MF: C₂₁H₁₅N₃O₄ / MW: 373.36
Bumetanide Related Compound B
United States Pharmacopeia (USP) Reference StandardCAS No: 28328-53-2 / MF: C₁₃H₁₀N₂O₇S / MW: 338.29
Ulipristal acetate
United States Pharmacopeia (USP) Reference StandardCAS No: 126784-99-4 / MF: C₃₀H₃₇NO₄ / MW: 475.62
Nateglinide impurity A
European Pharmacopoeia (EP) Reference StandardCAS No: 7077-05-6 / MF: C₁₀H₁₈O₂ / MW: 170.25
Zidovudine Related Compound D
United States Pharmacopeia (USP) Reference StandardCAS No: 50-89-5 / MF: C₁₀H₁₄N₂O₅ / MW: 242.23
Nilotinib
United States Pharmacopeia (USP) Reference StandardCAS No: 923288-90-8 / MF: C₂₈H₂₂F₃N₇O · HCl · H₂O / MW: 583.99
Acyclovir Related Compound A
United States Pharmacopeia (USP) Reference StandardCAS No: 102728-64-3 / MF: C₁₀H₁₃N₅O₄ / MW: 267.24
Nandrolone decanoate for peak identification
European Pharmacopoeia (EP) Reference StandardCAS No: 360-70-3 / MF: C₂₈H₄₄O₃ / MW: 428.65
Hawthorn dry extract for system suitability
HRS European Pharmacopoeia (EP) Reference Standard
Ramipril impurity C
European Pharmacopoeia (EP) Reference StandardCAS No: 99742-35-5 / MF: C₂₃H₃₈N₂O₅ / MW: 422.56
Sibutramine Related Compound B
United States Pharmacopeia (USP) Reference StandardMF: C₁₇H₂₆ClN · HCl / MW: 316.31
Dehydrocarteolol hydrochloride
United States Pharmacopeia (USP) Reference StandardCAS No: 53371-79-2 / MF: C₁₆H₂₂N₂O₃ · HCl / MW: 326.82
Triamterene Related Compound A
United States Pharmacopeia (USP) Reference StandardCAS No: 1006-23-1 / MF: C₄H₆N₆O / MW: 154.13
Cabazitaxel acetone CRS
European Pharmacopoeia (EP) Reference StandardCAS No: 1426815-65-7 / MF: C₄₅H₅₇NO₁₄·C₃H₆O / MW: 894.01